Cagrilintide 5mg+Semaglutide 5mg 10mg/vial Peptides Freeze-dried Powder

Cagrilintide 5mg+Semaglutide 5mg 10mg/vial Peptides Freeze-dried Powder
Product Introduction:
Cagrilintide (an amylin analog) and semaglutide (a GLP-1 agonist) act synergistically on the feeding center and gastrointestinal motility, strongly suppressing appetite and delaying gastric emptying. Phase III clinical trials have demonstrated superior weight loss (average weight loss exceeding 20%) compared to monotherapy, and have a comprehensive effect on improving cardiovascular and metabolic markers in patients with obesity and diabetes.
Send Inquiry
Description
Technical Parameters

Cagrilintide 5mg + Semaglutide 5mg 10mg/bottle combination peptide preparation core introduction

Pharmaceutical -grade peptide complex | Dual-action weight management formula

Ingredients Specifications :

Cagrilintide (long-acting amylin analog): 5 mg

Semaglutide (GLP-1 receptor agonist): 5 mg

Total content : 10mg/bottle

Dosage form : Lyophilized powder for injection

Appearance : White freeze-dried powder


Core Effects

This combination is a dual-mechanism weight management peptide combination that combines the satiety-enhancing function of Cagrilintide with the blood sugar regulation function of Semaglutide to achieve synergistic weight management and metabolic improvement .

✅ ​Dual synergistic mechanism :

Cagrilintide : Activates amylin receptors, delays gastric emptying, and enhances satiety

Semaglutide : Stimulates GLP-1 receptors, promotes insulin secretion, and inhibits glucagon

Synergistic effect : Dual pathways reduce appetite, slow gastrointestinal motility, and improve blood sugar control

✅ ​Metabolic regulation effect :

Appetite Suppressant : Significantly reduces hunger and reduces calorie intake

Blood sugar optimization : Improve insulin sensitivity and stabilize blood sugar levels

Weight Loss : Clinical studies show significant and sustained weight loss

✅ ​Clinical application value :

Obesity treatment : Adults with a BMI ≥ 30 kg/m² or ≥ 27 kg/m² with complications

Diabetes Management : Weight and Glycemic Control in Type 2 Diabetes

Metabolic improvement : Improves dyslipidemia and non-alcoholic fatty liver disease


Usage Protocol

1. Reconstitution Method :

Dilution options :

Sterile water for injection is recommended

Avoid using diluents containing preservatives

Preparation steps :

Disinfect the surface of the rubber stopper (wipe with 75% alcohol cotton pad)

Inject 1 ml of diluent (final concentration 10 mg/ml)

Gently rotate the bottle until completely dissolved, avoiding shock

The solution should be a clear liquid after preparation

2. Dosage regimen :

Starting dose :

Week 1: 0.25 mg once a week

Second week: 0.5 mg/time, once a week

Incremental plan :

Increase by 0.25-0.5 mg every month until the maintenance dose is reached

Maximum recommended dose: 2.4 mg/week

3. Injection technique :

Injection site :

Abdomen: area outside the umbilicus 5 cm

Thigh: anterolateral area

Upper arm: posterolateral region

Injection method :

Select the injection site and disinfect it

Pinch the skin and insert the needle at a 45-degree angle

Push the needle slowly and press the needle hole after injection


Storage Protocol

1. Storage of unreconstituted product :

Refrigerate :

Temperature: 2-8°C Refrigerate

Expiration date: Unopened product can be stored for 24 months

Note: Avoid freezing

Environmental requirements :

Store in original packaging away from light

Place in a dry environment

Keep out of reach of children

2. Storage after preparation :

Refrigerate :

Temperature: 2-8°C

Expiration date: Use within 56 days of preparation

Marking: Clearly mark the preparation date

Precautions for use :

Check solution clarity before each use

Do not use if turbidity or particles appear

Avoid repeated punctures of the rubber stopper

3. Transport Conditions :

Cold Chain Transport :

Transport temperature: 2-8°C

Packaging: Special cold chain box + ice pack

Time limit: Delivery within 48 hours

Acceptance Criteria :

Check the status of the ice pack

Confirm product integrity

Record transport temperature


Treatment Protocol

1. Obesity treatment :

Initial Assessment ​:

BMI measurement

Metabolic index testing

Complication assessment

Treatment Monitoring :

Weekly weight record

Monthly waist measurements

Regular review of metabolic indicators

2. Diabetes management :

Blood glucose monitoring :

fasting blood sugar

Postprandial blood sugar

Glycated hemoglobin

Dosage adjustments :

Adjust according to blood sugar control

Be aware of the risk of hypoglycemia

Combination medication evaluation


Why choose dual formula ?

Synergy ​: Dual action mechanism enhances weight loss effect

Sustained control ​: Long-acting formulations provide sustained blood drug concentrations

​Multiple benefits : Simultaneously achieve weight control and metabolic improvement


Conclusion

The combination of Cagrilintide and Semaglutide is an innovative weight management solution , delivering safe and effective weight control through a scientifically formulated dosage regimen and standardized injection technique . Choosing us means you'll receive high-quality products, professional guidance, and comprehensive service .

Need a personalized treatment plan ?

Welcome to contact our professional team to provide you with customized services!


Need anything, please contact us

WhatsApp

+852 4671 8216

Telegram

Allenraws

Email

Allenraws810@gmail.com

product-1268-769

 

Hot Tags: cagrilintide 5mg+semaglutide 5mg 10mg/vial peptides freeze-dried powder, China cagrilintide 5mg+semaglutide 5mg 10mg/vial peptides freeze-dried powder manufacturers, suppliers, factory, AOD9604 Ideal For Competition Prep Peak Weeks, ace 031 1mg, buy aod 9604 pills, peptide cjc ipamorelin, Alternative to GHRP 6, hgh ipamorelin

Send Inquiry
contact us